Israel Englander’s Decibel Therapeutics, Inc. Common Stock DBTX Stock Holding History

Israel Englander’s Portfolio DBTX Stock Details DBTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-159,224	Closed	-$613K	–	6770
2023 Q2	$613K	Sell	159,224 -87,093	-35%	-$320K	﹤0.01%	4401
2023 Q1	$744K	Sell	246,317 -242,466	-50%	-$838K	﹤0.01%	4340
2022 Q4	$1M	Buy	488,783 +171,491	+54%	+$523K	﹤0.01%	4167
2022 Q3	$1.1M	Buy	317,292 +52,720	+20%	+$240K	﹤0.01%	4257
2022 Q2	$1.11M	Buy	264,572 +225,498	+577%	+$533K	﹤0.01%	4264
2022 Q1	$119K	Buy	39,074 +418	+1%	+$1.6K	﹤0.01%	6069
2021 Q4	$180K	Buy	38,656 +120	+0.3%	+$826	﹤0.01%	5983
2021 Q3	$297K	Sell	38,536 -31,381	-45%	-$240K	﹤0.01%	5823
2021 Q2	$601K	Sell	69,917 -73,553	-51%	-$649K	﹤0.01%	5139
2021 Q1	$1.63M	Buy	+143,470	New	+$2.25M	﹤0.01%	3726

Other funds holding DBTX

ACA

Atlas Capital Advisors Jackson, Wyoming $914M AUM

Israel Englander's DBTX Position: Q3 2023 in Review

Israel Englander sold out of Decibel Therapeutics, Inc. Common Stock (DBTX) in Q3 2023, closing a stake of 159,224 shares — an estimated $613K sold.

Israel Englander first reported a position in DBTX in Q1 2021 and held it in 10 quarters. The position peaked at $1.63M in Q1 2021. 1 fund tracked by Wall St. Rank holds DBTX as of Q3 2023.

Israel Englander reported no remaining Decibel Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Israel Englander sold 159,224 Decibel Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $613K.
Israel Englander first reported a position in Decibel Therapeutics, Inc. Common Stock in Q1 2021 and held it in 10 quarters.
Israel Englander's Decibel Therapeutics, Inc. Common Stock position peaked at $1.63M in Q1 2021.
1 fund tracked by Wall St. Rank held Decibel Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Millennium Management's 13F filing for Q3 2023, filed 14 Nov 2023.